PRESS RELEASE published on 07/25/2024 at 14:01, 2 years 2 months ago Mainz Biomed Launches Enhanced ColoAlert with Cutting-Edge Features to Optimize Screening Efficiency and User Convenience Mainz Biomed launches enhanced ColoAlert test with new features to improve screening efficiency and user experience. The updates aim to optimize colorectal cancer detection ColoAlert Mainz Biomed Colorectal Cancer Screening Efficiency Enhanced Test
BRIEF published on 07/09/2024 at 09:06, 2 years 3 months ago Mainz Biomed Submits for FDA Breakthrough Device Designation for CRC Screening Test Mainz Biomed Colorectal Cancer FDA Submission Breakthrough Device Screening Test
BRIEF published on 07/09/2024 at 09:06, 2 years 3 months ago Mainz Biomed soumet une demande de désignation de dispositif révolutionnaire par la FDA pour le test de dépistage du CRC Cancer Colorectal Mayence Biomed Soumission À La FDA Appareil Révolutionnaire Test De Dépistage
PRESS RELEASE published on 07/09/2024 at 09:01, 2 years 3 months ago Mainz Biomed Announces Submission for FDA Breakthrough Device Designation for its Next Generation CRC Screening Test Mainz Biomed N.V. seeks FDA Breakthrough Device Designation for Next Generation CRC Screening Test with impressive clinical results Mainz Biomed N.V. Colorectal Cancer MRNA Biomarkers FDA Breakthrough Device Designation Next Generation CRC Screening Test
BRIEF published on 07/02/2024 at 14:06, 2 years 3 months ago Mainz Biomed Provides Half Year 2024 Corporate Update Diagnostic Solutions FDA Approval Mainz Biomed Colorectal Cancer Half Year Results
BRIEF published on 07/02/2024 at 14:06, 2 years 3 months ago Mainz Biomed fournit une mise à jour d'entreprise pour le semestre 2024 Résultats Semestriels Cancer Colorectal Mayence Biomed Approbation De La FDA Solutions De Diagnostic
PRESS RELEASE published on 07/02/2024 at 14:01, 2 years 3 months ago Mainz Biomed Provides Half Year 2024 Corporate Update Mainz Biomed N.V. provides corporate update for the first half of 2024, showcasing industry-leading clinical data and strategic partnerships. Expect half-year financial results in September 2024 Strategic Partnerships Corporate Update Clinical Data Mainz Biomed N.V. Half-year Financial Results
BRIEF published on 06/03/2024 at 14:06, 2 years 4 months ago Mainz Biomed Unveils Industry-Leading Study Results at ASCO 2024 Mainz Biomed MRNA Biomarkers ASCO 2024 CRC Detection Multimodal Screening
BRIEF published on 06/03/2024 at 14:06, 2 years 4 months ago Mainz Biomed dévoile les résultats d'une étude de pointe à l'ASCO 2024 Mayence Biomed Biomarqueurs D'ARNm ASCO 2024 Détection CRC Dépistage Multimodal
PRESS RELEASE published on 06/03/2024 at 14:01, 2 years 4 months ago Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024 Mainz Biomed presented industry-leading results of its pooled study at ASCO 2024, demonstrating high sensitivity in detecting colorectal cancer and precancerous lesions using mRNA biomarkers and AI algorithm Mainz Biomed Colorectal Cancer MRNA Biomarkers ASCO 2024 Precancerous Lesions
Published on 10/12/2026 at 15:00, 4 hours 15 minutes ago Shelfie-Tech Announces Closing of Private Placement
Published on 10/12/2026 at 13:00, 6 hours 15 minutes ago U.S. Energy Secretary Chris Wright, EXIM Chairman John Jovanovic, Nebraska Governor Jim Pillen, Senators Deb Fischer and Pete Ricketts, and Congressman Adrian Smith to Visit NioCorp's Critical Minerals Mine Site
Published on 10/10/2026 at 04:45, 2 days 14 hours ago Immutable Holdings and Jorge Masvidal's Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV
Published on 10/10/2026 at 02:03, 2 days 17 hours ago BrandPilot AI Announces Closing of Previously Announced Debt Settlement
Published on 10/10/2026 at 02:00, 2 days 17 hours ago Battery X Metals Reports Estimated Driving Range Increase of Approximately 101 Kilometers Following a Single-Electric-Vehicle Performance Evaluation of Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Technology
Published on 10/12/2026 at 19:00, 15 minutes ago PATRIMOINE ET COMMERCE : Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 5 octobre 2026 au 9 octobre 2026
Published on 10/12/2026 at 18:45, 30 minutes ago Fraikin announces exclusive agreement with Asterion Industrial Partners to support its next phase of growth
Published on 10/12/2026 at 18:00, 1 hour 15 minutes ago BIOSYNEX SA: BIOSYNEX annonce sa sortie de procédure de sauvegarde à la suite de l’arrêté de son plan de sauvegarde par le Tribunal Judiciaire de Strasbourg en date du 12 octobre 2026
Published on 10/12/2026 at 17:45, 1 hour 30 minutes ago EQS-Adhoc: Airbus SE: Airbus reports share buyback transactions 05-09 October 2026
Published on 10/12/2026 at 17:45, 1 hour 30 minutes ago VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 10/12/2026 at 17:59, 1 hour 16 minutes ago Reporting on share buyback transactions carried out between October 7 and October 9, 2026
Published on 10/12/2026 at 17:59, 1 hour 16 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 7 au 9 octobre 2026
Published on 10/12/2026 at 17:45, 1 hour 30 minutes ago Déclaration des transactions sur actions propres réalisées du 05/10/2026 au 11/10/2026